Show simple item record

dc.contributor.authorBurkill, Sen_US
dc.contributor.authorPorsbjerg, CMen_US
dc.contributor.authorBourdin, Aen_US
dc.contributor.authorTran, TNen_US
dc.contributor.authorMartin, Nen_US
dc.contributor.authorKatial, Ren_US
dc.contributor.authorBarker, Pen_US
dc.contributor.authorWechsler, MEen_US
dc.contributor.authorMaspero, Jen_US
dc.contributor.authorBosnic-Anticevich, Sen_US
dc.contributor.authorChung, LPen_US
dc.contributor.authorKatsoulotos, Gen_US
dc.contributor.authorChristoff, GCen_US
dc.contributor.authorPopov, TAen_US
dc.contributor.authorSadatsafavi, Men_US
dc.contributor.authorTorres-Duque, CAen_US
dc.contributor.authorUlrik, Cen_US
dc.contributor.authorAssing, KDen_US
dc.contributor.authorHansen, Sen_US
dc.contributor.authorAltraja, Aen_US
dc.contributor.authorLehtimaki, LAen_US
dc.contributor.authorPapadopoulos, NGen_US
dc.contributor.authorKostikas, Ken_US
dc.contributor.authorSalvi, Sen_US
dc.contributor.authorCostello, RWen_US
dc.contributor.authorFrancesca, Pen_US
dc.contributor.authorIwanaga, Ten_US
dc.contributor.authorRhee, CKen_US
dc.contributor.authorAl-Ahmad, Men_US
dc.contributor.authorLarenas-Linnemann, Den_US
dc.contributor.authorFonseca, JAen_US
dc.contributor.authorAmaral, Ren_US
dc.contributor.authorAlving, Ken_US
dc.contributor.authorAl-Lehebi, Ren_US
dc.contributor.authorDe-Llano, LPen_US
dc.contributor.authorKirenga, Ben_US
dc.contributor.authorTsai, Men_US
dc.contributor.authorMahboub, Ben_US
dc.contributor.authorPfeffer, PEen_US
dc.contributor.authorHenley, Wen_US
dc.contributor.authorLiu, Yen_US
dc.contributor.authorLyu, Jen_US
dc.contributor.authorGoh, Cen_US
dc.contributor.authorUthaman, Ten_US
dc.contributor.authorPrice, Den_US
dc.contributor.authorTownend, Jen_US
dc.date.accessioned2023-03-07T15:06:31Z
dc.date.issued2022en_US
dc.identifier.issn0903-1936en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/84829
dc.subjectSevere asthmaen_US
dc.subjectBiomarkersen_US
dc.subjectTreatmentsen_US
dc.titleReal-life biomarker response to anti-IL5 and anti-IgE therapies in severe asthma patientsen_US
dc.typeConference Proceeding
dc.identifier.doi10.1183/13993003.congress-2022.3305en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000893392404430&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume60en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record